SCHEMBL4276535

SCHEMBL4276535

CSc1ncc(CC(=O)O)c(Cl)n1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
AHR P35869 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NTRK1 P04629 1/20 0.38
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
THRB P10828 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15550707 0.87 MEN1 (0.49) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL23100081 0.84 MEN1 (0.50) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL9409997 0.83 MEN1 (0.45) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL12197610 0.80 MEN1 (0.47) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL29594221 0.80 MEN1 (0.47) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL16580715 0.80 MAPT (0.46) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL1404490 0.79 KDM4E (0.37) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL1355444 0.79 MEN1 (0.46) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL9591623 0.78 CYP19A1 (0.35) MEN1KMT2AMAPTKDM4ETDP1
SCHEMBL1226899 0.78 KDM4E (0.48) MEN1KMT2AMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016022644-A1 HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2016-02-11 WO disclosed
WO-2009152027-A1 5,7-DIHYDRO-6H-PYRROLO[2,3-D]PYRIMIDIN-6-ONE DERIVATIVES FOR MARK INHIBITION MERCK & CO., INC. (US) 2009-12-17 WO disclosed